BioFIT is now on LinkedIn!
This is the new BioFIT group on LinkedIn : BioFIT | A 360° approach to source Life Sciences early-stage innovations.
You will find there all the latest news of the event and you will be able to :
with all the members.
Do not hesitate to invite your connections to join this group!
Discover the BioFIT LinkedIn’s group Read More »
Juliane Proft is Project Manager in Oncology at IOCB (Institute of Organic Chemistry and Biochemistry), located in Prague, Czech Republic. IOCB is joining us to the 6th BioFit edition in order to present its technology, open for co-development and out licensing contact. She accepted to share with us the reasons why IOCB comes to BioFIT.
BioFIT : What is IOCB ?
Juliane Proft : IOCB is a public research institution located in Prague, Czech Republic, part of the Academy of Sciences. In more than 60 years of its history it has been focused on fundamental research in Organic Chemistry, Biochemistry, Theoretical Chemistry and Chemistry of Natural compounds. The institute has also a tradition in the translation of results from basic research into practical applications, mainly in the field of human and veterinary medicine. A prominent example is Tenoforvir, an HIV drug developed in collaboration with the KU Leuven and Gilead Scientific. This translational effort continues, in 2017 we have signed license agreements with two major partners.
IOCB TTO Group © – Juliane (on the front) and the rest of the group of IOCB
What are IOCB’s projects about ?
Most of our projects are developed around small molecules aiming at unmet medical needs like cancer, CNS diseases, viral and bacterial infections, metabolic syndrome and others. With around 40 research groups in various disciplines of chemistry, new projects are constantly evolving at the IOCB.
Why do you come to BioFIT ?
BioFIT is for us a good platform to meet with potential partners and we have made some fruitful connections in the past years. We are seeking for commercial partners to out-license and/or co-develop our technologies.
Many thanks to Juliane Proft for these comments.
BioFIT will bring together, in Marseille on December 12th and 13th, and online on December 15th, big pharma, emerging and small biotech, diagnostic companies, pre-seed, seed and Series A investors, as well as professionals from tech transfer, academia and research institutions from more than 35 countries. The event provides a unique opportunity to connect, network and explore new possibilities of partnering.
As an exhibitor, you will benefit from high visibility with key leaders in the Life Sciences sector.
Why should you book your stand today?
1️⃣ Showcase your innovative solutions to an international audience of decision-makers, investors, and potential collaborators.
2️⃣ Maximise your networking opportunities: meet leading experts, researchers, and industry professionals in the sector who can provide valuable insights, partnerships, and funding opportunities.
3️⃣ Highlight your organisation: by exhibiting at BioFIT you will benefit from extensive brand visibility (mention in our printed communication tools, highlight on the exhibition floor plan, additional visibility on our website) and recognition as a key player in the Life Sciences sector.
4️⃣ The early bird offer is still running, take advantage of a reduced fare before July 20th
Availability is limited, our stands will be allocated on a first-come, first-served basis.
They already booked their stand: Atlanpole, BIOCentre, Boehringer Ingelheim, CER Groupe, Charles River Laboratoires, Drugabilis, Eurofins Scientific, Genfit, Innoser, Inrae Transfert, Microsynth, NovaliX, Paras Biopharmaceuticals Finland Oy, Pfizer, Porton Pharmaceutical Chemicals GmbH, Roowin, SIMV, WAINVAM-E, Zoetis, and many others…
You can also register as a delegate with the Early Bird offer before July 20th, 2023.
If you are part of a BioFIT partner cluster or association, you can benefit from discounts on your pass:
contact them and register with their promo code.
Enhance your presence at BioFIT: Book your exhibition stand today! Read More »
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.
